Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

What is the Value of the Use of Validated Questionnaire (Reflux Impact Scale) for Predicting Treatment Success With PPI

NCT00536328 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00536328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00536328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
What is the Value of the Use of Validated Questionnaire (Reflux Impact Scale) for Predicting Treatment Success With PPI
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Terminated
Start date
October 31, 2007
Completion date
June 30, 2008
Enrollment
938 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acid regurgitation, gastroesophageal reflux disease, gerd, heartburn, retrosternal pain